The Impact on Recurrence Risk of Adjuvant Transarterial Chemoinfusion (TAI) for Patients With Hepatocellular Carcinoma And Microvascular Invasion (MVI) After Hepatectomy : A Random, Controlled, Stage III Clinical Trial.
Clinical trial NCT03192618 · UNKNOWN
Trial details
- NCT number
- NCT03192618
- Sponsor
- Sun Yat-sen University
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-01
- Primary completion
- 2022-12-31
- Enrollment
- 290
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.